BIOECONOMY
FOR CHANGE (B4C), an organization of 500+ companies, including commercial
organizations, academic bodies, and stakeholders has chosen BGN Technologies,
the technology transfer arm of Ben- Gurion University of the Negev, as a
strategic partner in Israel for locating advanced technologies in the emerging
field of synthetic biology.
The field of synthetic biology has exploded in recent years and especially at
Ben-Gurion University of the Negev. Researchers find advantages and solutions
in synthetic biology in a variety of fields such as cosmetics, agriculture,
disease detection, and therapeutics.
Since 2005, B4C has supported over 350+ international projects with an
estimated budget of 3 billion euros. The collaboration between BGN Technologies
and the members of B4C may result in joint ventures and the growth of start-up
companies that will promote the technologies developed at Ben-Gurion University
of the Negev.
With a track record of over 100 startup companies, as well as partnerships in
technology incubators and accelerators, BGN Technologies brings inventions from
the labs to the market, in the following fields: high-tech, biotechnology,
materials, agriculture, and environment. BGN Technologies fosters research
collaborations and entrepreneurship among researchers and students.
Johan De Coninck, a representative of B4C, stated that the choice of BGN
Technologies was natural due to their professional approach and proven
experience in growing technologies. He expressed confidence that the
cooperation will yield new ventures and financial investments in the future.
Josh Peleg, CEO of BGN Technologies, “We welcome the cooperation and I see it
as another indication of the international recognition of our groundbreaking
technologies.”
Pictured above: The B4C delegation meets with representatives from BGN Technologies Credit: Ira Golub BGN
